Résistance hormonale, méthylation et cancer du sein - CRCL

Résistance hormonale, méthylation et cancer du sein - CRCL

5
(477)
Write Review
More
$ 19.99
Add to Cart
In stock
Description

Les équipes de recherche du département TERI - CRCL

Mutation of Arginine 264 on ERα (Estrogen Receptor Alpha) Selectively Abrogates the Rapid Signaling of Estradiol in the Endothelium Without Altering Fertility - CRCL-Résistance hormonale, méthylation et cancer du sein

Muriel Le Romancer (CRCL) : Être ouvert à trouver des choses différentes - Tout Lyon

Interaction between N6-methyladenosine modification and the tumor microenvironment in colorectal cancer, Molecular Medicine

Androgen receptor gene methylation related to colorectal cancer risk in: Endocrine Connections Volume 8 Issue 7 (2019)

PDF) Altered BMP2/4 Signaling in Stem Cells and Their Niche: Different Cancers but Similar Mechanisms, the Example of Myeloid Leukemia and Breast Cancer

DNA methylation-based diagnostic, prognostic, and predictive biomarkers in colorectal cancer - ScienceDirect

Regulation of DNA methylation by ERRα reveals a role for IRF4 in breast cancer

Plateforme de Gestion des Echantillons Biologiques - PGEB - CRCL

Targeted DNA demethylation of the ZNF334 promoter inhibits colorectal cancer growth

Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer

Translational epigenetics in precision medicine of colorectal cancer - ScienceDirect

Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer